Stay updated with breaking news from Ivan Tornos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency1 basisFourth quarter diluted earnings per share were $2.01; adjusted1 diluted earnings per share were...
Company Sees Net Sales Increase and Provides Optimistic 2024 Guidance
Zimmer Biomet (NYSE: ZBH) shares slipped this morning despite fourth-quarter results that topped the consensus forecast.
Zimmer Biomet's Q4 2023 results, featuring 6.3% Y/Y net sales growth, $2.20 adjusted EPS, and a global restructuring plan for $200M cost savings.
"Discover the biggest shake-ups at Zimmer Biomet in 2023, from a new CEO appointment to biologics partnerships and record-breaking sales."